Vimarsana
Biggest News Aggregation in the World

Page 8 - Eqs Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Eqs Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Eqs Group Today - Breaking & Trending Today

EQS-Adhoc: RELIEF THERAPEUTICS Holding AG: Relief Reports U.S. Collaboration Partner Identifies Significantly Higher Likelihood of Surviving & Recovering from Critical COVID-19 in Aviptadil Treated Patients Previously Administered Remdesivir - Vimarsana News

EQS-Adhoc: RELIEF THERAPEUTICS Holding AG: Relief Reports U.S. Collaboration Partner Identifies Significantly Higher Likelihood of Surviving & Recovering from Critical COVID-19 in Aviptadil Treated Patients Previously Administered Remdesivir

EQS Group-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Study results Relief Reports U.S. Collaboration Partner Identifies Significantly Higher Likelihood of Surviving & Recovering from Critical

EQS-News: HSBC Continental Europe: Post Stabilisation Notice - Vimarsana News

EQS-News: HSBC Continental Europe: Post Stabilisation Notice

EQS Group-News: HSBC Continental Europe / Key word(s): Miscellaneous HSBC Continental Europe: Post Stabilisation Notice 26.11.2021 / 10:30 The issuer is solely responsible for the

EQS-Adhoc: Forbo Holding AG: Forbo launches fixed-price buyback offer - Vimarsana News

EQS-Adhoc: Forbo Holding AG: Forbo launches fixed-price buyback offer

EQS Group-Ad-hoc: Forbo Holding AG / Key word(s): Share Buyback Forbo launches fixed-price buyback offer 26-Nov-2021 / 07:08 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The

EQS-Adhoc: Forbo launches fixed-price buyback offer - Vimarsana News

EQS-Adhoc: Forbo launches fixed-price buyback offer

EQS Group-Ad-hoc: Forbo Holding AG / Key word(s): Share Buyback Forbo launches fixed-price buyback offer 26-Nov-2021 / 07:08 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. MEDIA RELEASE AD HOC announcement ...

EQS-Adhoc: IGEA Pharma N.V.: GBC AG PUBLISHES INITIAL EQUITY RESEARCH REPORT WITH BUY RECOMMENDATION AND PRICE TARGET OF EUR 1.05 - Vimarsana News

EQS-Adhoc: IGEA Pharma N.V.: GBC AG PUBLISHES INITIAL EQUITY RESEARCH REPORT WITH BUY RECOMMENDATION AND PRICE TARGET OF EUR 1.05

EQS Group-Ad-hoc: IGEA Pharma N.V. / Key word(s): Research Update/Research Update IGEA Pharma N.V.: GBC AG PUBLISHES INITIAL EQUITY RESEARCH REPORT WITH BUY RECOMMENDATION AND PRICE TARGET OF EUR 1.05